BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28017833)

  • 1. Protein Palmitoylation by ZDHHC13 Protects Skin against Microbial-Driven Dermatitis.
    Chen LY; Yang-Yen HF; Tsai CC; Thio CL; Chuang HL; Yang LT; Shen LF; Song IW; Liu KM; Huang YT; Liu FT; Chang YJ; Chen YT; Yen JJY
    J Invest Dermatol; 2017 Apr; 137(4):894-904. PubMed ID: 28017833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitoyl Acyltransferase Activity of ZDHHC13 Regulates Skin Barrier Development Partly by Controlling PADi3 and TGM1 Protein Stability.
    Chen LY; Lin KR; Chen YJ; Chiang YJ; Ho KC; Shen LF; Song IW; Liu KM; Yang-Yen HF; Chen YJ; Chen YT; Liu FT; Yen JJY
    J Invest Dermatol; 2020 May; 140(5):959-970.e3. PubMed ID: 31669413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous atopic dermatitis in mice with a defective skin barrier is independent of ILC2 and mediated by IL-1β.
    Schwartz C; Moran T; Saunders SP; Kaszlikowska A; Floudas A; Bom J; Nunez G; Iwakura Y; O'Neill L; Irvine AD; McKenzie ANJ; Ogg G; Walsh PT; Demengeot J; Fallon PG
    Allergy; 2019 Oct; 74(10):1920-1933. PubMed ID: 30937919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-33-Induced Atopic Dermatitis-Like Inflammation in Mice Is Mediated by Group 2 Innate Lymphoid Cells in Concert with Basophils.
    Imai Y; Yasuda K; Nagai M; Kusakabe M; Kubo M; Nakanishi K; Yamanishi K
    J Invest Dermatol; 2019 Oct; 139(10):2185-2194.e3. PubMed ID: 31121178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
    Kaesler S; Volz T; Skabytska Y; Köberle M; Hein U; Chen KM; Guenova E; Wölbing F; Röcken M; Biedermann T
    J Allergy Clin Immunol; 2014 Jul; 134(1):92-9. PubMed ID: 24698321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis of atopic dermatitis.
    Bonness S; Bieber T
    Curr Opin Allergy Clin Immunol; 2007 Oct; 7(5):382-6. PubMed ID: 17873576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice.
    Imai Y; Yasuda K; Sakaguchi Y; Haneda T; Mizutani H; Yoshimoto T; Nakanishi K; Yamanishi K
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13921-6. PubMed ID: 23918359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
    Chen L; Overbergh L; Mathieu C; Chan LS
    Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of interleukin-17 in mouse models of atopic dermatitis and contact dermatitis.
    Heo WI; Lee KE; Hong JY; Kim MN; Oh MS; Kim YS; Kim KW; Kim KE; Sohn MH
    Clin Exp Dermatol; 2015 Aug; 40(6):665-71. PubMed ID: 25684357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of the innate immune system in atopic dermatitis].
    Volz T; Kaesler S; Skabytska Y; Biedermann T
    Hautarzt; 2015 Feb; 66(2):90-5. PubMed ID: 25633721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunologic aspects of atopic dermatitis.
    Lipozencić J; Pastar Z; Kulisić SM; Pavić I
    Acta Dermatovenerol Croat; 2009; 17(3):226-34. PubMed ID: 19818224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes.
    Rebane A; Runnel T; Aab A; Maslovskaja J; Rückert B; Zimmermann M; Plaas M; Kärner J; Treis A; Pihlap M; Haljasorg U; Hermann H; Nagy N; Kemeny L; Erm T; Kingo K; Li M; Boldin MP; Akdis CA
    J Allergy Clin Immunol; 2014 Oct; 134(4):836-847.e11. PubMed ID: 24996260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of peptidoglycan recognition proteins on experimental atopic and contact dermatitis mediated by Treg and Th17 cells.
    Park SY; Gupta D; Kim CH; Dziarski R
    PLoS One; 2011; 6(9):e24961. PubMed ID: 21949809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in atopic dermatitis.
    Peng W; Novak N
    Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):417-22. PubMed ID: 25090248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of skin barrier proteins and cytokines in adults with atopic dermatitis.
    Orfali RL; Zaniboni MC; Aoki V
    G Ital Dermatol Venereol; 2017 Apr; 152(2):140-147. PubMed ID: 27982552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Features between Chronic Skin Inflammatory Diseases Revealed in Skin-Humanized Psoriasis and Atopic Dermatitis Mouse Models.
    Carretero M; Guerrero-Aspizua S; Illera N; Galvez V; Navarro M; García-García F; Dopazo J; Jorcano JL; Larcher F; del Rio M
    J Invest Dermatol; 2016 Jan; 136(1):136-45. PubMed ID: 26763433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zdhhc13-dependent Drp1 S-palmitoylation impacts brain bioenergetics, anxiety, coordination and motor skills.
    Napoli E; Song G; Liu S; Espejo A; Perez CJ; Benavides F; Giulivi C
    Sci Rep; 2017 Oct; 7(1):12796. PubMed ID: 29038583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights in the pathogenesis of atopic dermatitis.
    Ong PY
    Pediatr Res; 2014 Jan; 75(1-2):171-5. PubMed ID: 24192701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin barrier and immune dysregulation in atopic dermatitis: an evolving story with important clinical implications.
    Czarnowicki T; Krueger JG; Guttman-Yassky E
    J Allergy Clin Immunol Pract; 2014; 2(4):371-9; quiz 380-1. PubMed ID: 25017523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Innate immunity in atopic dermatitis.
    Mrabet-Dahbi S; Maurer M
    Curr Probl Dermatol; 2011; 41():104-111. PubMed ID: 21576951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.